A fibrillin-1 (Fbn1)-target knock-in mutant mice displayed several features of a systemic sclerosis-like disease, including skin fibrosis, immune cell activation, and autoimmunity with antinuclear and anti-topoisomerase I antibodies, but did not develop microvascular changes [22]. This evidence concerns the gene FBN1 and Autoimmunity.